| [1] |
Chandwani R，Allen PJ.Cystic Neoplasms of the Pancreas[J]．Annu Rev Med，2016，67(1)：45-57.
|
| [2] |
Gardner TB，Park WG，Allen PJ.Diagnosis and Management of Pancreatic Cysts[J]．Gastroenterology，2024，167(3)：454-468.
|
| [3] |
Farrell JJ，Fernández-del Castillo C．Pancreatic Cystic Neoplasms: Management and Unanswered Questions[J]．Gastroenterology，2013, 144(6)：1303-1315.
|
| [4] |
Farrell JJ.Prevalence，Diagnosis and Management of Pancreatic Cystic Neoplasms：Current Status and Future Directions[J]．Gut Liver，2015, 9(5)：571-589.
|
| [5] |
Ardeshna DR，Cao T，Rodgers B，et al.Recent advances in the diagnostic evaluation of pancreatic cystic lesions[J]．World J Gastroenterol, 2022，28(6)：624-634.
|
| [6] |
Li SY，Wang ZJ，Pan CY，et al.Comparative Performance of Endoscopic Ultrasound-Based Techniques in Patients With Pancreatic Cystic Lesions：A Network Meta-Analysis[J]．Am J Gastroenterol，2023, 118(2)：243-255.
|
| [7] |
Thomas DR，Scott NE.Glycoproteomics：growing up fast[J]．Curr Opin Struct Biol，2021，68(1)：18-25.
|
| [8] |
Li J，Zhao T，Li J，et al.Precision N-glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma [J]．Mol Oncol，2022，16(11)：2135.
|
| [9] |
Costa J，Streich L，Pinto S，et al.Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis[J]．Mol Neurobiol，2019，56(8)：5729-5739.
|
| [10] |
Cao Z，Maupin K，Curnutte B，et al.Specific Glycoforms of MUC5AC and Endorepellin Accurately Distinguish Mucinous from Nonmucinous Pancreatic Cysts[J]．Mol Cell Proteomics，2013，12(10): 2724-2734.
|
| [11] |
Haab BB，Porter A，Yue T，et al.Glycosylation Variants of Mucins and CEACAMs as Candidate Biomarkers for the Diagnosis of Pancreatic Cystic Neoplasms[J]．Ann Surg，2010，251(5)：937-945.
|
| [12] |
Cui M，Hu Y，Zhang Z，et al.Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm[J]．Signal Transduct Target Ther，2023，8(1)：406-415.
|
| [13] |
Nieminen H，Nummela P，Satomaa T，et al.N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm[J]．Sci Rep，2023，13(1)：13191-13202.
|
| [14] |
刘璐瑶，秦洪强，叶明亮．完整糖基化肽段的富集与质谱解析新技术研究进展[J]．色谱，2021，39(10)：1045-1054.
|
| [15] |
孟凡刚，孟雅冰．蛋白质组学与应用[M]．北京：化学工业出版社，2022.
|
| [16] |
沈百荣，黄健．蛋白质组信息学[M]．北京：科学出版社，2023.
|
| [17] |
高春芳．糖基化：未来可期的新型疾病标志物[J]．中华检验医学杂志，2022，45(4)：315-317.
|
| [18] |
Wang Y，Sun Y，Feng J，et al.Glycopatterns and Glycoproteins Changes in MCN and SCN：A Prospective Cohort Study[J]．Biomed Res Int，2019，2019：2871289.
|
| [19] |
Carrara S，Cangi MG，Arcidiacono PG，et al.Mucin Expression Pattern in Pancreatic Diseases：Findings From EUS-Guided Fine-Needle Aspiration Biopsies[J]．Am J Gastroenterol，2011，106(7)：1359-1363.
|
| [20] |
Kwon RS，Simeone DM.The Use of Protein-Based Biomarkers for the Diagnosis of Cystic Tumors of the Pancreas[J]．Int J Proteomics, 2011，2011：1-9.
|
| [21] |
Furukawa T，Klöppel G，Volkan Adsay N，et al.Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study[J]．Virchows Arch，2005，447(5)：794-799.
|
| [22] |
Furukawa T，Hatori T，Fujita I，et al.Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas[J]．Gut，2011，60(4)：509-516.
|
| [23] |
Dalton CJ，Lemmon CA.Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling[J]．Cells，2021，10(9)：2443.
|
| [24] |
Topalovski M，Brekken RA.Matrix control of pancreatic cancer：new insights into fibronectin signaling[J]．Cancer Letters，2015，381(1): 252-258.
|
| [25] |
Paulo JA，Kadiyala V，Banks PA，et al.Mass Spectrometry-Based (GeLC-MS/MS) Comparative Proteomic Analysis of Endoscopically (ePFT) Collected Pancreatic and Gastroduodenal Fluids[J]．Clin Transl Gastroenterol，2012，3(5)：e14-e23.
|
| [26] |
Moore PC，Cortez JT，Chamberlain CE，et al.Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma [J]．J Clin Invest，2019，129(11)：4676-4681.
|
| [27] |
Zhu G，Fang Q，Zhu F，et al.Structure and Function of Pancreatic Lipase-Related Protein 2 and Its Relationship With Pathological States[J]．Front Genet，2021，12：693538.
|
| [28] |
Cater JH，Wilson MR，Wyatt AR.Alpha-2-Macroglobulin，a Hypochlorite-Regulated Chaperone and Immune System Modulator [J]．Oxid Med Cell Longev，2019，2019：5410657.
|
| [29] |
Tomihari A，Kiyota M，Matsuura A，et al.Alpha 2-macroglobulin acts as a clearance factor in the lysosomal degradation of extracellular misfolded proteins[J]．Sci Rep，2023，13(1)：4680.
|
| [30] |
Jaldín-Fincati JR，Actis Dato V，Díaz NM，et al.Activated α2-Macroglobulin Regulates LRP1 Levels at the Plasma Membrane through the Activation of a Rab10-dependent Exocytic Pathway in Retinal Müller Glial Cells[J]．Sci Rep，2019，9(1)：13234.
|